These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36853000)

  • 1. Repurposing Axl Kinase Inhibitors for the Treatment of Respiratory Syncytial Virus Infection.
    Zhang D; Zhao Y; You X; He S; Li E
    Antimicrob Agents Chemother; 2023 Mar; 67(3):e0148722. PubMed ID: 36853000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Axl Mediates Resistance to Respiratory Syncytial Virus Infection Independent of Cell Attachment.
    Zhang D; Zhao Y; Wang L; You X; Li J; Zhang G; Hou Y; Wang H; He S; Li E
    Am J Respir Cell Mol Biol; 2022 Aug; 67(2):227-240. PubMed ID: 35548971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Axl receptor blockade ameliorates pulmonary pathology resulting from primary viral infection and viral exacerbation of asthma.
    Shibata T; Habiel DM; Coelho AL; Kunkel SL; Lukacs NW; Hogaboam CM
    J Immunol; 2014 Apr; 192(8):3569-81. PubMed ID: 24659691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of antiviral activity of the new hDHODH inhibitor MEDS433 against respiratory syncytial virus replication.
    Luganini A; Sibille G; Pavan M; Mello Grand M; Sainas S; Boschi D; Lolli ML; Chiorino G; Gribaudo G
    Antiviral Res; 2023 Nov; 219():105734. PubMed ID: 37852322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribavirin treatment up-regulates antiviral gene expression via the interferon-stimulated response element in respiratory syncytial virus-infected epithelial cells.
    Zhang Y; Jamaluddin M; Wang S; Tian B; Garofalo RP; Casola A; Brasier AR
    J Virol; 2003 May; 77(10):5933-47. PubMed ID: 12719586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aesculus hippocastanum L. seed extract shows virucidal and antiviral activities against respiratory syncytial virus (RSV) and reduces lung inflammation in vivo.
    Salinas FM; Vázquez L; Gentilini MV; O Donohoe A; Regueira E; Nabaes Jodar MS; Viegas M; Michelini FM; Hermida G; Alché LE; Bueno CA
    Antiviral Res; 2019 Apr; 164():1-11. PubMed ID: 30711418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labyrinthopeptins as virolytic inhibitors of respiratory syncytial virus cell entry.
    Blockus S; Sake SM; Wetzke M; Grethe C; Graalmann T; Pils M; Le Goffic R; Galloux M; Prochnow H; Rox K; Hüttel S; Rupcic Z; Wiegmann B; Dijkman R; Rameix-Welti MA; Eléouët JF; Duprex WP; Thiel V; Hansen G; Brönstrup M; Haid S; Pietschmann T
    Antiviral Res; 2020 May; 177():104774. PubMed ID: 32197980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
    Salinas FM; Nebreda AD; Vázquez L; Gentilini MV; Marini V; Benedetti M; Nabaes Jodar MS; Viegas M; Shayo C; Bueno CA
    Antiviral Res; 2020 Jul; 179():104817. PubMed ID: 32387475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulatory Defective Viral Genomes from Respiratory Syncytial Virus Promote a Strong Innate Antiviral Response during Infection in Mice and Humans.
    Sun Y; Jain D; Koziol-White CJ; Genoyer E; Gilbert M; Tapia K; Panettieri RA; Hodinka RL; López CB
    PLoS Pathog; 2015 Sep; 11(9):e1005122. PubMed ID: 26336095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Efficacy of a Respiratory Syncytial Virus (RSV) Fusion Inhibitor in a Bovine Model of RSV Infection.
    Jordan R; Shao M; Mackman RL; Perron M; Cihlar T; Lewis SA; Eisenberg EJ; Carey A; Strickley RG; Chien JW; Anderson ML; McEligot HA; Behrens NE; Gershwin LJ
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4889-900. PubMed ID: 26055364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral efficacy of a respiratory syncytial virus inhibitor in rodent models of infection.
    Cianci C; Genovesi EV; Lamb L; Medina I; Yang Z; Zadjura L; Yang H; D'Arienzo C; Sin N; Yu KL; Combrink K; Li Z; Colonno R; Meanwell N; Clark J; Krystal M
    Antimicrob Agents Chemother; 2004 Jul; 48(7):2448-54. PubMed ID: 15215093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Respiratory Syncytial Virus Infection on Host Functions: Implications for Antiviral Strategies.
    Hu M; Bogoyevitch MA; Jans DA
    Physiol Rev; 2020 Oct; 100(4):1527-1594. PubMed ID: 32216549
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis.
    Antunes KH; Stein RT; Franceschina C; da Silva EF; de Freitas DN; Silveira J; Mocellin M; Leitão L; Fachi JL; Pral LP; Gonzalez A; Oliveira S; Duarte L; Cassão G; Gonçalves JIB; Reis TM; Abbadi BL; Dornelles M; Sperotto NDM; Rigo M; Rodrigues H; Jones M; Epifanio M; Guima S; Setubal JC; Jorge TR; Mansur DS; Mayer FQ; Varela APM; Bizarro CV; Machado P; Basso LA; Polack FP; Custovic A; Vinolo MAR; de Souza APD
    EBioMedicine; 2022 Mar; 77():103891. PubMed ID: 35220042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Respiratory syncytial virus: prospects for new and emerging therapeutics.
    Jorquera PA; Tripp RA
    Expert Rev Respir Med; 2017 Aug; 11(8):609-615. PubMed ID: 28574729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening and pharmacodynamic evaluation of the antirespiratory syncytial virus activity of steroidal pyridine compounds in vitro and in vivo.
    Wang Z; Hou D; Fang J; Zhu L; Sun Y; Tan Y; Gu Z; Shan L
    J Med Virol; 2021 Jun; 93(6):3428-3438. PubMed ID: 33064304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral effects of modified dingchuan decoction against respiratory syncytial virus infection in vitro and in an immunosuppressive mouse model.
    Li L; Yu CH; Ying HZ; Yu JM
    J Ethnopharmacol; 2013 May; 147(1):238-44. PubMed ID: 23506991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy, TGF-β, and SMAD-2/3 Signaling Regulates Interferon-β Response in Respiratory Syncytial Virus Infected Macrophages.
    Pokharel SM; Shil NK; Bose S
    Front Cell Infect Microbiol; 2016; 6():174. PubMed ID: 28018859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines.
    Fuentes S; Arenas D; Moore MM; Golding H; Khurana S
    Vaccine; 2017 Jan; 35(4):694-702. PubMed ID: 27989627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity and regulation of alpha interferon in respiratory syncytial virus and human metapneumovirus experimental infections.
    Guerrero-Plata A; Baron S; Poast JS; Adegboyega PA; Casola A; Garofalo RP
    J Virol; 2005 Aug; 79(16):10190-9. PubMed ID: 16051812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antiviral efficacies of small-molecule inhibitors against respiratory syncytial virus based on the F protein.
    Dai P; Ruan P; Mao Y; Tang Z; Bajinka O; Wu G; Tan Y
    J Antimicrob Chemother; 2022 Dec; 78(1):169-179. PubMed ID: 36322459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.